Related Experiment Video
Updated: Nov 25, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study.
Roberto Bizzotto1, Christopher Jennison2, Angus G Jones3,4
1CNR Institute of Neuroscience, Padova, Italy roberto.bizzotto@cnr.it.
Glycemic deterioration in type 2 diabetes (T2D) is driven by declining insulin sensitivity, impaired beta-cell function, and increased insulin clearance. Stabilizing these factors can help prevent disease progression.
Area of Science:
- Metabolic disease research
- Endocrinology
- Diabetes management
Background:
- Type 2 diabetes (T2D) is characterized by progressive hyperglycemia.
- Understanding the underlying mechanisms of glycemic deterioration is crucial for effective T2D management.
Purpose of the Study:
- To investigate the key metabolic processes contributing to worsening glycemic control in recently diagnosed T2D patients.
- To identify predictive factors for rapid glycemic deterioration.
Main Methods:
- Longitudinal phenotyping of 732 T2D patients over 3 years.
- Assessed insulin sensitivity (OGIS), beta-cell glucose sensitivity (GS), and insulin clearance (CLIm) using mixed meal tests.
- Utilized multivariable regression to analyze associations between metabolic patterns and HbA1c progression.
Main Results:
- Faster HbA1c progression was linked to declining OGIS, GS, and increasing CLIm.
- Visceral/liver fat and lipid profiles also independently, though weakly, correlated with glycemic deterioration.
- A stable single trait (OGIS, GS, or CLIm) significantly reduced the proportion of fast progressors.
Conclusions:
- Worsening insulin sensitivity, beta-cell function, insulin clearance, and metabolic factors drive T2D glycemic deterioration.
- Maintaining stable insulin sensitivity, beta-cell function, or insulin clearance may be key to preventing disease progression.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

